SCHEMBL22267906

SCHEMBL22267906

CC(C)NCCc1cnn(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 4/20 0.43
HAT1 O14929 2/20 0.43
PDE10A Q9Y233 1/20 0.42
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HRH4 Q9H3N8 2/20 0.35
HRH3 Q9Y5N1 2/20 0.35
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104235 0.81 ALDH1A1 (0.43) PDE10AALDH1A1SMN1; SMN2L3MBTL1MEN1
SCHEMBL3509780 0.79 PDE10A (0.45) EP300HAT1PDE10ANPC1RAB9A
SCHEMBL13710517 0.76 LNPEP (0.37) EP300HAT1PDE10ANPC1RAB9A
SCHEMBL17788488 0.74 HCAR2 (0.46) RAB9AALDH1A1KDM4ELMNAGAA
SCHEMBL6133076 0.74 PDE10A (0.41) EP300HAT1PDE10ANPC1RAB9A
SCHEMBL23610743 0.73 NPC1 (0.43) EP300HAT1PDE10ANPC1RAB9A
SCHEMBL23610744 0.73 NPC1 (0.43) EP300HAT1PDE10ANPC1RAB9A
SCHEMBL16869469 0.73 LNPEP (0.36) PDE10ANPC1RAB9AALDH1A1HTT
SCHEMBL8342570 0.72
SCHEMBL3327111 0.72 JAK2 (0.40) EP300HAT1PDE10AOPRM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723727-B2 Tubulysin analogs and methods for their preparation PFIZER INC. (US) 2020-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723727-B2 Tubulysin analogs and methods for their preparation NGLY1, TEK, TEKT1 EP300 4758/4885HAT1 4602/4885PDE10A 4667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.